Hamilton Lane Advisors LLC Nevro Corp Transaction History

Hamilton Lane Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 16, 2018	SELL	$44.22 - $75.47 $2.1 Million - $3.58 Million	-47,475 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$72.38 - $92.5 $2.72 Million - $3.47 Million	37,564 Added 379.01%	47,475 $4,000
Q1 2018 May 03, 2018	SELL	$69.46 - $88.57 $924,512 - $1.18 Million	-13,310 Reduced 57.32%	9,911 $1,000
Q4 2017 Jan 17, 2018	BUY	$65.94 - $93.31 $1.31 Million - $1.86 Million	19,905 Added 600.27%	23,221 $1.6 Million
Q3 2017 Oct 16, 2017	BUY	$80.87 - $91.08 $268,164 - $302,021	3,316	3,316 $301,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.